Proud to have been a part of this
@polybiorf.bsky.social effort to describe the path forward for
#LongCOVID trials targeting SARS-CoV-2 persistence. We need a robust biomarker development program and to launch more trials to rigorously test treatments that target these pathways now.
add a skeleton here at some point
9 months ago
